Original Article
Determining safe washout period for immune checkpoint inhibitors prior to liver transplantation: An international retrospective cohort study
Moeckli et al.
#LiverXtinyurl.com/yrt77t4k
Last year's #ILCA Annual Conference brought together doctors, nurses, patients, caregivers, & industry to discuss #livercancer advancements.🎥
#ILCA25 will continue to drive this collaboration in Hong Kong, Nov 19-21, 2025. Join us: ilcalive.org/annual-conferen…
What percentage of the population in Latin America is affected by liver diseases?
🤔 Think you know? The answer is hidden in our Special Issue on "Hot Topics in Hepatology!" 🧐
#Hepatology#LiverHealth
We’ve just concluded our V Annual HCC Course at @HospitalAustral!
Over two incredible days, hepatologists, oncologists, radiologists, and surgeons shared best practices and insights on HCC management through engaging cases and interactive roundtables.
Thank you to everyone!
📢 V Curso Anual de HCC @HospitalAustral
🔔clase magistral de @fedepfc Cómo interpretar los ensayos clínicos?
Asociación vs correlación
Eficacia vs efectividad
Superioridad vs no inferioridad
Error alfa y error beta
@BallenDF
Muchas gracias @fedepfc y @Mmendizabal por la invitación al curso formando parte de la delegacion Uruguaya y personalmente por la participación en la mesa de HCC e HTPortal. Un honor. Excelente instancia de discusión y aprendizaje!
📢 V Curso Anual de HCC @HospitalAustral
Participantes regionales de 11 países incluyendo hepatólogos, radiólogos, oncologos y cirujanos.
Aquí mesa redonda discutiendo la valoración de la hipertensión portal en pacientes con HCC.
📢 V Curso Anual de HCC @HospitalAustral
🔔@barrosonco nos aclara conceptos SBRT
Algunos usos:
👉Metástasis extrahepáticas
👉No respondedores a TACE
🚨Mucha precaución en pacientes Child B >=8
Se viene SBRT mas inmunoterapia? 🤔
📢 Live from #TLM2024@fedepfc pesenting the Latin American perspective on IO for HCC
➡️ Low screening rates and late-stage diagnoses 🫤
➡️ Challenges with IO approval 🫤
➡️ But promising real-world outcomes ☺️
@AASLDtweets
Happy to see my friend and colleague @fedepfc as a speaker today in this nice session about "Global Perspectives on HCC".
Even better when the session is moderated by @JoseDebesMD
Latin America is going to be very well represented.
@HospitalAustral#TLM24
📢 now on #TLM2024
Fede Piñero ➡️ considerations in pts with systemic treatment for HCC:
- Age
- Portal thrombosis
- Comorbidities
- Decompensation
- And more
@AASLDtweets@alehlatam
Await further news about registration (F2F and remote) We have set up an interactive program with international experts to provide updated knowledge @hospitalclinic @idibaps @CIBERehd @_SEOM @AEEHLiver @EASLnews @ILCAnews